Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report

BACKGROUND: In vitro studies confirmed cytoreductive anti-tumor activity of crizotinib in experimental models of anaplastic large cell lymphoma in 2007. One case series and a few case reports describe the use of crizotinib in relapsed or refractory anaplastic lymphoma kinase-positive anaplastic larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothari, Shalin, Ud-Din, Najam, Lisi, Michele, Coyle, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908805/
https://www.ncbi.nlm.nih.gov/pubmed/27301488
http://dx.doi.org/10.1186/s13256-016-0963-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908805/
https://www.ncbi.nlm.nih.gov/pubmed/27301488
http://dx.doi.org/10.1186/s13256-016-0963-y

Ejemplares similares